tiprankstipranks
Advertisement
Advertisement
Analyst Reiterates Buy on Dexcom, Citing Strong Q2 Growth, Expanding G7 Adoption and CMS Coverage Upside
PremiumRatingsAnalyst Reiterates Buy on Dexcom, Citing Strong Q2 Growth, Expanding G7 Adoption and CMS Coverage Upside
17d ago
Early notable gainers among liquid option names on July 31st
Premium
The Fly
Early notable gainers among liquid option names on July 31st
17d ago
DexCom price target raised to $92 from $86 at Deutsche Bank
Premium
The Fly
DexCom price target raised to $92 from $86 at Deutsche Bank
17d ago
DexCom price target raised to $95 from $90 at Mizuho
PremiumThe FlyDexCom price target raised to $95 from $90 at Mizuho
17d ago
DexCom price target raised to $82 from $65 at JPMorgan
Premium
The Fly
DexCom price target raised to $82 from $65 at JPMorgan
17d ago
DexCom price target raised to $105 from $80 at Baird
Premium
The Fly
DexCom price target raised to $105 from $80 at Baird
17d ago
DexCom reports Q2 EPS 70c, consensus 61c
PremiumThe FlyDexCom reports Q2 EPS 70c, consensus 61c
18d ago
DexCom sees FY25 revenue $5.15B-$5.25B, consensus $5.22B
Premium
The Fly
DexCom sees FY25 revenue $5.15B-$5.25B, consensus $5.22B
18d ago
DexCom options imply 6.7% move in share price post-earnings
Premium
The Fly
DexCom options imply 6.7% move in share price post-earnings
18d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100